Gene · 5451
Papers3,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression. | Exp Ther Med | 2018 | 30116332 | PubTator, text mining | PubMed |
| Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses. | Front Genet | 2018 | 30116257 | PubTator, text mining | PubMed |
| Pharmacogenomics of analgesics in anesthesia practice: A current update of literature. | J Anaesthesiol Clin Pharmacol | 2018 | 30104820 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) polymerase 1 searches DNA via a 'monkey bar' mechanism. | Elife | 2018 | 30088474 | PubTator, text mining | PubMed |
| The canonical Wnt/β-catenin signaling pathway stimulates herpes simplex virus 1 productive infection. | Virus Res | 2018 | 30077727 | PubTator, text mining | PubMed |
| Coordinating Mitochondrial Biology Through the Stress-Responsive Regulation of Mitochondrial Proteases. | Int Rev Cell Mol Biol | 2018 | 30072094 | PubTator, text mining | PubMed |
| Three newly identified Immediate Early Genes of Bovine herpesvirus 1 lack the characteristic Octamer binding motif- 1. | Sci Rep | 2018 | 30061689 | PubTator, text mining | PubMed |
| Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches. | Clin Pharmacol Ther | 2018 | 30059145 | PubTator, text mining | PubMed |
| Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways. | Cancer Commun (Lond) | 2018 | 30053908 | PubTator, text mining | PubMed |
| CIGene: a literature-based online resource for cancer initiation genes. | BMC Genomics | 2018 | 30045691 | PubTator, text mining | PubMed |
| The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells. | Oncotarget | 2018 | 30042821 | PubTator, text mining | PubMed |
| Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells. | J Exp Clin Cancer Res | 2018 | 30029680 | PubTator, text mining | PubMed |
| Significance of miR-15a-5p and CNKSR3 as Novel Prognostic Biomarkers in Non-Small Cell Lung Cancer. | Anticancer Agents Med Chem | 2018 | 30019650 | PubTator, text mining | PubMed |
| Strength in diversity: Understanding the pathways to herpes simplex virus reactivation. | Virology | 2018 | 30014861 | PubTator, text mining | PubMed |
| Elucidating feed-forward apoptosis signatures in breast cancer datasets: Higher FOS expression associated with a better outcome. | Oncol Lett | 2018 | 30013671 | PubTator, text mining | PubMed |
| BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer. | Cancer Res | 2018 | 30012673 | PubTator, text mining | PubMed |
| Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer. | Cells | 2018 | 30011957 | PubTator, text mining | PubMed |
| H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units. | Nucleic Acids Res | 2018 | 30010961 | PubTator, text mining | PubMed |
| miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. | J Exp Med | 2018 | 29997117 | PubTator, text mining | PubMed |
| Assessment of Transporter-Mediated and Passive Hepatic Uptake Clearance Using Rifamycin-SV as a Pan-Inhibitor of Active Uptake. | Mol Pharm | 2018 | 29996058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5451/papers?page=61